Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19 (2024)
- Authors:
- Ferreira, Rafael R.
- Martins, Ronaldo B.
- Pires, Isabela Batista

- Marques, Bruno Lemes

- Costa, Karla C.M.
- Lirio, Pedro Henrique Cassario

- Scomparin, Davi Silveira

- Scarante, Franciele Franco

- Batah, Sabrina Setembre

- Hallak, Jaime Eduardo Cecilio

- Crippa, José Alexandre de Souza

- Rodrigues, Livia C. M.

- Tostes, Rita de Cássia Aleixo

- Fabro, Alexandre Todorovic

- Arruda, Eurico

- Campos, Alline Cristina de

- USP affiliated authors: HALLAK, JAIME EDUARDO CECILIO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; PASSAGLIA, RITA DE CASSIA ALEIXO TOSTES - FMRP ; FABRO, ALEXANDRE TODOROVIC - FMRP ; ARRUDA NETO, EURICO DE - FMRP ; CAMPOS, ALLINE CRISTINA DE - FMRP ; MARQUES, BRUNO LEMES - FMRP ; LIRIO, PEDRO HENRIQUE CASSARO - FMRP ; SCOMPARIN, DAVI SILVEIRA - FMRP ; BATAH, SABRINA SETEMBRE - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.bbih.2024.100855
- Subjects: COVID-19; DOENÇAS CARDIOVASCULARES; NEFROPATIAS; INFLAÇÃO
- Keywords: SARS-CoV-2; Severe COVID-19; Neuroinflammation; Cardiovascular disease; BDNF; Kidney disease
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2024
- Source:
- Título: Brain, Behavior, & Immunity - Health
- ISSN: 2666-3546
- Volume/Número/Paginação/Ano: v. 41, art. 100855, 2024
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FERREIRA, Rafael R. et al. Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19. Brain, Behavior, & Immunity - Health, v. 41, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.bbih.2024.100855. Acesso em: 14 fev. 2026. -
APA
Ferreira, R. R., Martins, R. B., Pires, I. B., Marques, B. L., Costa, K. C. M., Lirio, P. H. C., et al. (2024). Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19. Brain, Behavior, & Immunity - Health, 41. doi:10.1016/j.bbih.2024.100855 -
NLM
Ferreira RR, Martins RB, Pires IB, Marques BL, Costa KCM, Lirio PHC, Scomparin DS, Scarante FF, Batah SS, Hallak JEC, Crippa JA de S, Rodrigues LCM, Tostes R de CA, Fabro AT, Arruda E, Campos AC de. Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19 [Internet]. Brain, Behavior, & Immunity - Health. 2024 ; 41[citado 2026 fev. 14 ] Available from: https://doi.org/10.1016/j.bbih.2024.100855 -
Vancouver
Ferreira RR, Martins RB, Pires IB, Marques BL, Costa KCM, Lirio PHC, Scomparin DS, Scarante FF, Batah SS, Hallak JEC, Crippa JA de S, Rodrigues LCM, Tostes R de CA, Fabro AT, Arruda E, Campos AC de. Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19 [Internet]. Brain, Behavior, & Immunity - Health. 2024 ; 41[citado 2026 fev. 14 ] Available from: https://doi.org/10.1016/j.bbih.2024.100855 - Cannabidiol as an antipsychotic drug
- Pulmonary pathology of ARDS in COVID-19: a pathological review for clinicians
- Production and evaluation of leukocyte- and thrombocyte-rich fibrin membranes in birds
- A rat model of neurocysticercosis-induced hydrocephalus: chronic progressive hydrocephalus with mild clinical impairment
- Cannabidiol: pharmacodynamics and pharmacokinetic in the context of neuropsychiatric disorders
- Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes
- Neuroprotective effects of cannabidiol in human neural cell lines infected with SARS-CoV-2
- Dr Harley Quinn, the villain from Gotham City with dependent personality disorder. [Carta]
- Cannabidiol as a promising strategy to treat and prevent movement disorders?
- The therapeutic potential of harmine and ayahuasca in depression: evidence from exploratory animal and human studies
Informações sobre o DOI: 10.1016/j.bbih.2024.100855 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
| 003254485.pdf | Direct link | ||
| 003254485.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
